Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

NCT07275359 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07275359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07275359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
October 2, 2029
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)